Cargando…

Human bone marrow-derived mesenchymal stem overexpressing microRNA-124-3p inhibit DLBCL progression by downregulating the NFATc1/cMYC pathway

BACKGROUND: Exosomes play important roles in intercellular communication by delivering microRNAs (miRNAs) that mediate tumor initiation and development, including those in diffuse large B cell lymphoma (DLBCL). To date, however, limited studies on the inhibitory effect of exosomes derived from human...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xiaoxuan, Xu, Mingxi, Hu, Xuemeng, Ding, Xiaolei, Zhang, Xian, Xu, Liye, Li, Li, Sun, Xiuhua, Song, Jincheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228039/ https://www.ncbi.nlm.nih.gov/pubmed/37248542 http://dx.doi.org/10.1186/s13287-023-03373-w

Ejemplares similares

A proteomic study of cMyc improvement of CHO culture
por: Kuystermans, Darrin, et al.
Publicado: (2010)

Temporal Requirements of cMyc Protein for Reprogramming Mouse Fibroblasts
por: Heffernan, Corey, et al.
Publicado: (2012)

MiR-200c is a cMyc-activated miRNA that promotes nasopharyngeal carcinoma by downregulating PTEN
por: Chen, Pan, et al.
Publicado: (2016)

TRIM66 Overexpression Promotes Glioma Progression and Regulates Glucose Uptake Through cMyc/GLUT3 Signaling
por: Song, Yuequn, et al.
Publicado: (2021)

Transformation of normal cells by aberrant activation of YAP via cMyc with TEAD
por: Nishimoto, Masazumi, et al.
Publicado: (2019)

PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis
por: Qin, Yi, et al.
Publicado: (2019)

SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of cMYC oncoprotein
por: Geng, Chuandong, et al.
Publicado: (2017)

Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma
por: Lin, Yun Hsiao, et al.
Publicado: (2021)

The SIRT2/cMYC Pathway Inhibits Peroxidation-Related Apoptosis In Cholangiocarcinoma Through Metabolic Reprogramming
por: Xu, Lei, et al.
Publicado: (2019)

Transition from cMyc to L-Myc during dendritic cell development coordinated by rising levels of IRF8
por: Anderson, David A., et al.
Publicado: (2021)

Convergence of cMyc and β‐catenin on Tcf7l1 enables endoderm specification
por: Morrison, Gillian, et al.
Publicado: (2015)

cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis
por: Sakr, Hany I., et al.
Publicado: (2017)

Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer
por: Zhu, Hongwen, et al.
Publicado: (2023)

Association of CMYC polymorphisms with hepatoblastoma risk
por: Yang, Tianyou, et al.
Publicado: (2020)

Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
por: Loftus, Róisín M., et al.
Publicado: (2018)

AID expression levels determine the extent of cMyc oncogenic translocations and the incidence of B cell tumor development
por: Takizawa, Makiko, et al.
Publicado: (2008)

Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis
por: Figueiredo, Jane C, et al.
Publicado: (2007)

cMyc increases cell number through uncoupling of cell division from cell size in CHO cells
por: Kuystermans, Darrin, et al.
Publicado: (2009)

The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc()()
por: Prensner, John R., et al.
Publicado: (2014)

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
por: Nyquist, Michael D., et al.
Publicado: (2023)

Targeting EFNA1 suppresses tumor progression via the cMYC-modulated cell cycle and autophagy in esophageal squamous cell carcinoma
por: Jiang, Houxiang, et al.
Publicado: (2023)

Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc
por: Luo, Haitao, et al.
Publicado: (2010)

Sequence-to-expression approach to identify etiological non-coding DNA variations in P53 and cMYC-driven diseases
por: Kin, Katherine, et al.
Publicado: (2023)

Alisertib Added to Rituximab and Vincristine Is Synthetic Lethal and Potentially Curative in Mice with Aggressive DLBCL Co-Overexpressing MYC and BCL2
por: Mahadevan, Daruka, et al.
Publicado: (2014)

Concomitant Classic Hodgkin Lymphoma of Lymph Node and cMYC-Positive Burkitt Leukemia/Lymphoma of the Bone Marrow Presented Concurrently at the Time of Presentation: A Rare Combination of Discordant Lymphomas
por: Soliman, Dina S., et al.
Publicado: (2016)

Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming
por: Simula, Luca, et al.
Publicado: (2018)

RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site
por: George, Jasmine, et al.
Publicado: (2021)

cMyc/miR-125b-5p Signalling Determines Sensitivity to Bortezomib in Preclinical Model of Cutaneous T-Cell Lymphomas
por: Manfè, Valentina, et al.
Publicado: (2013)

Secondary hemophagocytic lymphohistiocytosis triggered by peripheral T‐cell lymphoma: An unusual case report
por: Che, Yuxuan, et al.
Publicado: (2022)

Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements
por: Eertink, J. J., et al.
Publicado: (2021)

Osteoblasts-Derived Exosomal lncRNA-MALAT1 Promotes Osteoclastogenesis by Targeting the miR-124/NFATc1 Signaling Axis in Bone Marrow-Derived Macrophages
por: Zhang, Chenyi, et al.
Publicado: (2023)

A novel rapid-onset high-penetrance plasmacytoma mouse model driven by deregulation of cMYC cooperating with KRAS12V in BALB/c mice
por: Hu, Y, et al.
Publicado: (2013)

microRNA-155 positively regulates glucose metabolism via PIK3R1-FOXO3a-cMYC axis in breast cancer
por: Kim, Sinae, et al.
Publicado: (2018)

Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study
por: Khan, Umair Tahir, et al.
Publicado: (2021)

The Immunology of DLBCL
por: Takahara, Taishi, et al.
Publicado: (2023)

Overexpression of microRNA-124 promotes the neuronal differentiation of bone marrow-derived mesenchymal stem cells
por: Zou, Defeng, et al.
Publicado: (2014)

MiR-30a Inhibits the Epithelial—Mesenchymal Transition of Podocytes through Downregulation of NFATc3
por: Peng, Rui, et al.
Publicado: (2015)

NFATc2-dependent epigenetic downregulation of the TSC2/Beclin-1 pathway is involved in neuropathic pain induced by oxaliplatin
por: Liu, Meng, et al.
Publicado: (2023)

Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
por: Witte, Hanno M., et al.
Publicado: (2023)

NFATC1 and NFATC2 expression patterns in human osteochondromas
por: Wang, Yuanyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_408tdd7f77qchmjh6fcllgrvak